Treatment of herpes simplex virus types 1 and 2 encephalitis in mice with 9-beta-D-arabinofuranosyladenine
about
Activities of 5,6-dihydro-5-azathymidine against herpes simplex virus infections in miceHerpes simplex virus skin infection in hairless mice: treatment with antiviral compoundsComparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in micePhosphonoacetic acid-resistant herpes simplex virus infection in hairless mice.Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyladenine.Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesisChemotherapy of genital herpes simplex virus type 2 infections of female hamsters.Therapy of experimental herpes simplex encephalitis with aciclovir in miceInhibition of experimental deoxyribonucleic acid virus-induced encephalitis by 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphateTesting of antiviral compounds against Mengo virus infection of mice. A 2-step procedure of in vivo screening.Uptake of 5(125I) iodo-2-deoxyuridine (IDU) in plasma and cerebrospinal fluid in a case of herpes encephalitis with a comparative study on the uptake in plasma, cerebrospinal fluid and brain tissue in dogs.Synergistic effects of antiviral agents and humoral antibodies in experimental Herpesvirus hominis encephalitis.Effects of adenine arabinoside on cellular immune mechanisms in humans.Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.
P2860
Q28325788-C47EBB9F-70EA-4659-BD66-6AEAAE1A7982Q28364199-FC0BD33F-E2E4-41C7-B65B-CCF8476AC1D0Q28366970-D851C60A-F804-4091-8DBD-1552C8C0A031Q34920900-45B7BD1A-6AD0-4D21-8907-71A0AF36E97CQ34927859-980800D2-A9E2-4E07-9B0E-0F8D09334CD6Q35668550-528A33DE-33E8-4D05-8B4C-46325BB2802DQ36462126-EABDBD72-EAAF-4737-B43F-912BCED3F00BQ36480860-A104113D-AF7A-4B94-99CE-1CF36DC274DAQ39960616-D869739C-10D2-448F-802C-7F4A6ABBD82BQ40017477-F45A8AA2-23B6-48B1-A7B2-E9B11C54AD0CQ40094812-318073F5-917F-4748-8C9D-18063BC603C7Q40560085-98C7B63F-B372-4D63-9214-36C89A271ABDQ40943861-3975753D-6554-4763-AD8E-B547FE08A2DBQ42926902-C817AB89-9E29-45DE-A644-6320882E191D
P2860
Treatment of herpes simplex virus types 1 and 2 encephalitis in mice with 9-beta-D-arabinofuranosyladenine
description
1973 nî lūn-bûn
@nan
1973 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Treatment of herpes simplex vi ...... beta-D-arabinofuranosyladenine
@ast
Treatment of herpes simplex vi ...... beta-D-arabinofuranosyladenine
@en
Treatment of herpes simplex vi ...... beta-D-arabinofuranosyladenine
@nl
type
label
Treatment of herpes simplex vi ...... beta-D-arabinofuranosyladenine
@ast
Treatment of herpes simplex vi ...... beta-D-arabinofuranosyladenine
@en
Treatment of herpes simplex vi ...... beta-D-arabinofuranosyladenine
@nl
prefLabel
Treatment of herpes simplex vi ...... beta-D-arabinofuranosyladenine
@ast
Treatment of herpes simplex vi ...... beta-D-arabinofuranosyladenine
@en
Treatment of herpes simplex vi ...... beta-D-arabinofuranosyladenine
@nl
P2093
P2860
P356
P1476
Treatment of herpes simplex vi ...... beta-D-arabinofuranosyladenine
@en
P2093
P2860
P356
10.1128/AAC.3.1.74
P407
P577
1973-01-01T00:00:00Z